Rosalie M. Luiten

8.3k total citations · 3 hit papers
83 papers, 5.5k citations indexed

About

Rosalie M. Luiten is a scholar working on Immunology, Cell Biology and Oncology. According to data from OpenAlex, Rosalie M. Luiten has authored 83 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 36 papers in Cell Biology and 20 papers in Oncology. Recurrent topics in Rosalie M. Luiten's work include melanin and skin pigmentation (36 papers), Immunotherapy and Immune Responses (32 papers) and T-cell and B-cell Immunology (24 papers). Rosalie M. Luiten is often cited by papers focused on melanin and skin pigmentation (36 papers), Immunotherapy and Immune Responses (32 papers) and T-cell and B-cell Immunology (24 papers). Rosalie M. Luiten collaborates with scholars based in Netherlands, United States and Belgium. Rosalie M. Luiten's co-authors include Arthur Kammeyer, Hergen Spits, J.P.W. van der Veen, Jacqueline Limpens, Peter A. van Veelen, Eric A. Reits, Jan D. Bos, Jasper G. van den Boorn, Elizabeth K. Wansley and Elly Mesman and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Rosalie M. Luiten

82 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

2006 1.3k citations Eric A. Reits, James W. Hodge et al. The Journal of Experimental Medicine profile →
Oxidation events and skin aging

2015 712 citations Rosalie M. Luiten et al. profile →
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis

2015 435 citations Jacqueline Limpens, Aeilko H. Zwinderman et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosalie M. Luiten Netherlands	30	2.8k	2.1k	1.5k	1.2k	1.1k	83	5.5k
Shigetoshi Sano Japan	42	2.8k 1.0×	2.0k 1.0×	490 0.3×	1.5k 1.3×	2.0k 1.9×	169	6.4k
Hajime Iizuka Japan	38	1.5k 0.5×	576 0.3×	986 0.7×	1.6k 1.4×	1.7k 1.6×	211	5.0k
Mayumi Fujita United States	34	1.4k 0.5×	1.0k 0.5×	442 0.3×	561 0.5×	1.9k 1.8×	131	4.1k
Kaoru Kiguchi United States	36	1.1k 0.4×	1.9k 0.9×	484 0.3×	520 0.4×	3.0k 2.8×	77	5.3k
Dagmar Kulms Germany	32	968 0.4×	762 0.4×	403 0.3×	937 0.8×	2.1k 2.0×	70	3.8k
Jean‐Paul Ortonne France	54	2.9k 1.0×	578 0.3×	4.5k 3.0×	3.4k 3.0×	2.6k 2.5×	140	9.9k
C D Bucana United States	40	1.3k 0.5×	2.0k 1.0×	329 0.2×	591 0.5×	2.7k 2.5×	81	5.7k
Beate M. Czarnetzki Germany	41	2.0k 0.7×	438 0.2×	780 0.5×	1.3k 1.2×	1.0k 1.0×	185	5.0k
Henry Hennings United States	42	581 0.2×	1.2k 0.6×	2.1k 1.4×	899 0.8×	4.0k 3.7×	118	7.1k
John T. Seykora United States	35	708 0.3×	1.3k 0.6×	908 0.6×	1.1k 1.0×	2.2k 2.1×	108	4.8k

Countries citing papers authored by Rosalie M. Luiten

Since Specialization

Citations

This map shows the geographic impact of Rosalie M. Luiten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalie M. Luiten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalie M. Luiten more than expected).

Fields of papers citing papers by Rosalie M. Luiten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalie M. Luiten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalie M. Luiten. The network helps show where Rosalie M. Luiten may publish in the future.

Co-authorship network of co-authors of Rosalie M. Luiten

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalie M. Luiten. A scholar is included among the top collaborators of Rosalie M. Luiten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalie M. Luiten. Rosalie M. Luiten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuijk, Sander M. J. van, Iwan C.C. van der Horst, Rosalie M. Luiten, et al.. (2025). More self‐efficacy is associated with longitudinally higher health‐related quality of life in mechanically ventilated COVID ‐19 ICU survivors: The prospective MaastrICCht cohort. Nursing in Critical Care. 30(4). e13241–e13241. 1 indexed citations

Willemsen, Marcella, Jenny Bulgarelli, Sudhir Kumar Chauhan, et al.. (2024). Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy. Immuno-Oncology Technology. 24. 101009–101009. 4 indexed citations

Ouwerkerk, Wouter, et al.. (2023). The Risk of Keratinocyte Cancer in Vitiligo and the Potential Mechanisms Involved. Journal of Investigative Dermatology. 144(2). 234–242. 7 indexed citations

Uden, N. van, et al.. (2023). Trained immunity in the pathogenesis of vitiligo. Pigment Cell & Melanoma Research. 36(5). 348–354. 12 indexed citations

Rønnstad, Amalie Thorsti Møller, Lene Bay, Anne‐Sofie Halling, et al.. (2023). Defining the temporal relationship between the skin microbiome, immune response and skin barrier function during flare and resolution of atopic dermatitis: protocol of a Danish intervention study. BMJ Open. 13(2). e068395–e068395. 3 indexed citations

Willemsen, Marcella, et al.. (2021). Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in the Peripheral Blood of Patients with Segmental and Nonsegmental Vitiligo. Journal of Investigative Dermatology. 142(3). 876–883.e3. 20 indexed citations

Verdaasdonk, Rudolf M., et al.. (2020). Ultraviolet photography in vitiligo: image quality, validity and reliability. Journal of the European Academy of Dermatology and Venereology. 34(7). 1590–1594. 7 indexed citations

Tio, Darryl, Marcella Willemsen, Rick Hoekzema, et al.. (2020). Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma. American Journal of Dermatopathology. 42(8). 625–627. 25 indexed citations

Tio, Darryl, Marcella Willemsen, Remco van Doorn, et al.. (2019). Expression of cancer/testis antigens in cutaneous melanoma: a systematic review. Melanoma Research. 29(4). 349–357. 16 indexed citations

10.

Willemsen, Marcella, et al.. (2019). Skin‐resident memory T cells as a potential new therapeutic target in vitiligo and melanoma. Pigment Cell & Melanoma Research. 32(5). 612–622. 30 indexed citations

11.

Eby, Jonathan M., Angela R. Smith, Timothy P. Riley, et al.. (2018). Molecular properties of gp100‐reactive T‐cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells. Pigment Cell & Melanoma Research. 32(1). 68–78. 10 indexed citations

12.

Boorn, Jasper G. van den, Christopher Jakobs, Marcel Renn, et al.. (2016). Inflammasome-Dependent Induction of Adaptive NK Cell Memory. Immunity. 44(6). 1406–1421. 68 indexed citations

13.

Limpens, Jacqueline, et al.. (2015). Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. 33(7). 773–781. 435 indexed citations breakdown →

14.

Vrijman, Charlotte, et al.. (2012). Provoking factors, including chemicals, in Dutch patients with vitiligo. British Journal of Dermatology. 168(5). 1003–1011. 26 indexed citations

15.

Tjin, Esther P.M., Debby Konijnenberg, Henk Mallo, et al.. (2011). T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy. Clinical Cancer Research. 17(17). 5736–5747. 32 indexed citations

16.

Mollet, Ilse, Sofie De Schepper, Esther P.M. Tjin, et al.. (2010). First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell & Melanoma Research. 23(3). 375–384. 68 indexed citations

17.

Reits, Eric A., James W. Hodge, Carla Herberts, et al.. (2006). Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. The Journal of Experimental Medicine. 203(5). 1259–1271. 1346 indexed citations breakdown →

18.

Boorn, Jasper G. van den, Cecele J. Denman, Mingli Li, et al.. (2006). Therapeutic implications of autoimmune vitiligo T cells. Autoimmunity Reviews. 5(7). 486–492. 69 indexed citations

19.

Luiten, Rosalie M., Esther W. M. Kueter, Wolter J. Mooi, et al.. (2005). Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients. Journal of Clinical Oncology. 23(35). 8978–8991. 90 indexed citations

20.

Luiten, Rosalie M., et al.. (1996). Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigen.. PubMed. 74(2). 467–75. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact